CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($) $ in Thousands	9 Months Ended
	Jun. 30, 2023	Jun. 30, 2022
Operating activities
Net income	$ 4,090	$ 19,846
Adjustments to reconcile net income to net cash provided by (used in) operating activities:
Depreciation and amortization	11,281	5,740
Amortization of deferred financing costs charged to interest expense	1,540	497
Stock-based compensation expense	2,020	1,952
Deferred Income Tax Expense (Benefit)	0	(1)
Changes in operating assets and liabilities
Increase (Decrease) in Accounts Receivable	(1,918)	(16,890)
Increase (Decrease) in Other Current Assets	130	(152)
Accrued payroll	274	4,032
Deferred revenue	0	(22,273)
Accounts payable and accrued liabilities	(4,221)	2,380
Other long-term assets and liabilities	1,801	110
Net cash provided by (used in) operating activities	14,997	(4,759)
Investing activities
Business acquisition, net of cash acquired	(180,711)	0
Purchase of equipment and improvements	(580)	(244)
Net cash used in investing activities	(181,291)	(244)
Financing activities
Proceeds from revolving line of credit	144,697	0
Repayment of revolving line of credit	(128,204)	0
Proceeds from debt obligations	168,000	13,500
Repayments of debt obligations	(10,688)	(31,750)
Payments of deferred financing costs	(7,666)	0
Proceeds from issuance of common stock upon exercise of options and warrants	1,107	543
Payment of tax obligations resulting from net exercise of stock options	(650)	(281)
Net cash provided by (used in) financing activities	166,596	(17,988)
Net change in cash	302	(22,991)
Cash - beginning of period	228	24,051
Cash - end of period	530	1,060
Supplemental disclosure of cash flow information
Cash paid during the period for interest	10,006	1,195
Cash paid during the period for income taxes	4,055	6,403
Common stock surrendered for the exercise of stock options	$ 238	$ 256